While precision medicine has been proven to help patients, very few studies have looked at how it impacts African Americans.
ITM investigators – including David Meltzer, Doriane Miller, Robert Grossman, and Peter O’Donnell – and Northwestern University have teamed up to launch The African American Pharmacogenomic Consortium Network Transdisciplinary Collaborative Center (ACCOuNT TCC) to:
- engage community leaders in this research
- develop a precision medicine initiative for African Americans to see if the practice is as helpful to them as those of European descent
- support researchers who are studying how African American genetics impact responses to medications
ACCOuNT is offering a Pilot Grant Program with administrative support from the ITM to stimulate community stakeholders to be the principal drivers of pharmacogenomics-enabling research projects that they conceive, plan, and execute with support from research collaborators.
Two projects focused on cardiovascular pharmacogenomics, or how a person’s genes impact their reaction to drugs for the heart and blood vessels, will be awarded each year. Awards will be made for up to $25,000 for each project.
The application deadline is September 15, 2017. View the RFA here and at the below button, and contact ITM investigator Doriane Miller, MD, at email@example.com with questions or for help finding a research or community partner.